Method for increasing mean survival times of transplants with LFA-1-specific antibodies
US6214342A · kind A · utility
28Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 1995 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Oct 30, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mean survival times of a functional transplant of solid organs in a patient are increased by administering to the patient an initial dosing of a therapeutically effective amounts of a monoclonal antibody directed against the human LFA-1 molecule in the two hours after grafting and then administering daily dosing during a period of approximately nine days.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.